Study of Rifaximin in Minimal Hepatic Encephalopathy

NCT01069133 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

FED

Sponsor class

Conditions

Minimal Hepatic Encephalopathy

Interventions

DRUG: Rifaximin
DRUG: rifaximin

Sponsor

Hunter Holmes Mcguire Veteran Affairs Medical Center

Collaborators

[object Object]